Edwards Lifesciences Corporation
MX ˙ BMV ˙ US28176E1082
SecurityMX:EW / Edwards Lifesciences Corporation
InstitutionNixon Peabody Trust Co
Latest Disclosed Ownership5,791 shares
Latest Disclosed Value $ 463,743
Nixon Peabody Trust Co reports 10.34% decrease in ownership of EW / Edwards Lifesciences Corporation

On April 27, 2026 - Nixon Peabody Trust Co filed a 13F-HR form disclosing ownership of 5,791 shares of Edwards Lifesciences Corporation (MX:EW) valued at $463,743 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 6,459 shares of Edwards Lifesciences Corporation. This represents a change in shares of -10.34% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-27 2026-03-31 13F Edwards Lifesciences Com 28176E108 5,791 -668 -10.34 464 -15.82 0.0369
2026-02-06 2025-12-31 13F Edwards Lifesciences Com 28176E108 6,459 -622 -8.78 551 0.00 0.0417
2025-10-17 2025-09-30 13F Edwards Lifesciences Com 28176E108 7,081 -220 -3.01 551 -3.68 0.0403
2025-08-08 2025-06-30 13F Edwards Lifesciences Com 28176E108 7,301 -47 -0.64 571 7.33 0.0442
2025-04-10 2025-03-31 13F Edwards Lifesciences Com 28176E108 7,348 -328 -4.27 533 -6.34 0.0452
2025-02-05 2024-12-31 13F Edwards Lifesciences Com 28176E108 7,676 29 0.38 568 12.70 0.0468
2024-11-07 2024-09-30 13F Edwards Lifesciences Com 28176E108 7,647 -550 -6.71 505 -33.42 0.0420
2024-07-26 2024-06-30 13F Edwards Lifesciences Com 28176E108 8,197 -733 -8.21 757 -11.25 0.0673
2024-05-07 2024-03-31 13F Edwards Lifesciences Com 28176E108 8,930 495 5.87 853 32.66 0.0784
2024-02-09 2023-12-31 13F Edwards Lifesciences Com 28176E108 8,435 8,435 643 0.0721
2022-05-12 2022-03-31 13F Edwards Lifesciences Com 28176E108 0 -7,806 -100.00 0 -100.00
2022-02-08 2021-12-31 13F Edwards Lifesciences Com 28176E108 7,806 7,806 1,011 0.3061
2021-11-04 2021-09-30 13F EDWARDS LIFESCIENCES CORP COM Common Stock 28176E108 0 -1,934 -100.00 0 -100.00
2021-07-30 2021-06-30 13F EDWARDS LIFESCIENCES CORP COM Common Stock 28176E108 1,934 1,934 200 0.0770
2021-04-24 2021-03-31 13F EDWARDS LIFESCIENCES Common Stock 28176E108 0 -2,226 -100.00 0 -100.00
2021-02-10 2020-12-31 13F EDWARDS LIFESCIENCES Common Stock 28176E108 2,226 2,226 203 0.0856
2020-04-22 2020-03-31 13F EDWARDS LIFESCIENCES Common Stock 28176E108 0 -1,049 -100.00 0 -100.00
2020-01-24 2019-12-31 13F EDWARDS LIFESCIENCES Common Stock 28176E108 1,049 -35 -3.23 245 2.94 0.1220
2019-11-04 2019-09-30 13F EDWARDS LIFESCIENCES Common Stock 28176E108 1,084 -503 -31.70 238 -18.77 0.1268
2019-08-01 2019-06-30 13F EDWARDS LIFESCIENCES Common Stock 28176E108 1,587 -445 -21.90 293 -24.68 0.1651
2019-04-19 2019-03-31 13F EDWARDS LIFESCIENCES Common Stock 28176E108 2,032 -613 -23.18 389 -3.95 0.2549
2019-01-23 2018-12-31 13F EDWARDS LIFESCIENCES CP Common Stock 28176E108 2,645 -280 -9.57 405 -20.43 0.3192
2018-10-25 2018-09-30 13F EDWARDS LIFESCIENCES CP Common Stock 28176E108 2,925 -1,825 -38.42 509 -26.34 0.3478
2018-07-30 2018-06-30 13F EDWARDS LIFESCIENCES CP Common Stock 28176E108 4,750 -1,805 -27.54 691 -24.48 0.5357
2018-04-27 2018-03-31 13F EDWARDS LIFESCIENCES CP Common Stock 28176E108 6,555 -1,745 -21.02 915 -2.24 0.8202
2018-02-05 2017-12-31 13F EDWARDS LIFESCIENCES CP Common Stock 28176E108 8,300 -185 -2.18 936 0.97 0.8064
2017-11-01 2017-09-30 13F EDWARDS LIFESCIENCES CP Common Stock 28176E108 8,485 -1,375 -13.95 927 -20.50 0.8421
2017-07-17 2017-06-30 13F EDWARDS LIFESCIENCES CP Common Stock 28176E108 9,860 -1,430 -12.67 1,166 9.79 1.0793
2017-04-06 2017-03-31 13F EDWARDS LIFESCIENCES CP Common Stock 28176E108 11,290 -1,320 -10.47 1,062 -10.15 0.9995
2017-01-18 2016-12-31 13F EDWARDS LIFESCIENCES CP Common Stock 28176E108 12,610 -740 -5.54 1,182 -26.54 1.1510
2016-10-24 2016-09-30 13F EDWARDS LIFESCIENCES CP Common Stock 28176E108 13,350 -2,480 -15.67 1,609 1.90 1.5795
2016-07-08 2016-06-30 13F EDWARDS LIFESCIENCES CP Common Stock 28176E108 15,830 -3,295 -17.23 1,579 -6.40 1.3710
2016-04-20 2016-03-31 13F EDWARDS LIFESCIENCES CP Common Stock 28176E108 19,125 -515 -2.62 1,687 8.77 1.5005
2016-01-13 2015-12-31 13F EDWARDS LIFESCIENCES CP Common Stock 28176E108 19,640 19,640 1,551 1.4138
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.